Earliest Clues of Breast Cancer in Seniors and Kisqali Treatment
What Is Breast Cancer?
Breast cancer is a type of cancer that forms in the cells of the breasts. It usually starts in the milk-producing glands (lobules) or the ducts that carry milk to the nipple. Breast cancer can spread to other parts of the body, such as the lymph nodes or bones, if left untreated. The most common type of breast cancer is invasive ductal carcinoma, which means the cancer has spread outside of the ducts into the surrounding breast tissue.
What Are the Earliest Clues of Breast Cancer in Seniors?
Seniors may experience different signs and symptoms of breast cancer compared to younger adults. Some of the earliest clues of breast cancer in seniors can include:
- Changes in the shape or size of the breast
- Unusual discharge from the nipple
- Inverted nipple
- Lump or thickening in the breast or underarm
- Redness or rash on the breast
These symptoms may also be accompanied by pain or discomfort in the breast or armpit area. It is important to note that the above symptoms can also be caused by other conditions, and not all lumps are cancerous. However, if you notice any of these changes, it is essential to consult your doctor for further evaluation and proper diagnosis.
Why Is Early Detection Important?
Early detection of breast cancer is crucial for successful treatment and improved survival rates. When breast cancer is caught at an early stage, it is smaller in size and has not spread to other parts of the body. This makes it easier to treat and increases the chances of a full recovery. On the other hand, if breast cancer is not detected early, it may grow and spread, making it more difficult to treat and potentially resulting in a lower survival rate.
What Is Kisqali and How Does It Work?
Kisqali (ribociclib) is a prescription medicine used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It belongs to a class of drugs known as CDK4/6 inhibitors and works by blocking two proteins (CDK4 and CDK6) that help cancer cells grow and divide. Kisqali is used in combination with an aromatase inhibitor or fulvestrant, and it is taken in pill form once a day.
How Effective Is Kisqali Treatment?
Several studies have shown that Kisqali treatment is highly effective in treating advanced or metastatic breast cancer in both pre- and post-menopausal women. In a phase III clinical trial, Kisqali in combination with an aromatase inhibitor was found to prolong progression-free survival compared to the aromatase inhibitor alone. This means that patients who received Kisqali treatment had a longer period without the disease worsening. Kisqali has also been shown to reduce the risk of cancer spreading or death in patients with no previous treatment for advanced breast cancer.
What Are the Side Effects of Kisqali?
As with any medication, Kisqali may cause side effects in some patients. The most common side effects include:
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Decreased appetite
Other, less common side effects may include low white blood cell count, increased liver enzymes, and abnormal heartbeat. It is essential to discuss any potential side effects with your doctor before starting Kisqali treatment.
Conclusion
In conclusion, breast cancer is a prevalent disease, especially among seniors. While it may be challenging to detect in its earliest stages, paying attention to the earliest clues and seeking medical attention can lead to early detection and better treatment outcomes. Kisqali is a promising treatment option for advanced or metastatic breast cancer, with studies showing its effectiveness in prolonging progression-free survival. If you or a loved one are experiencing any of the earliest clues of breast cancer, do not hesitate to consult a doctor for proper evaluation and treatment.